Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation FLDM today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in the upcoming 29th Annual Piper Jaffray Healthcare Conference in New York, NY.

Linthwaite will take part in a fireside chat presentation on Tuesday, November 28, 2017, at 4:30 pm ET at the Lotte New York Palace Hotel.

A live webcast of the company's presentation and subsequent replay may be accessed at http://investors.fluidigm.com/events.cfm. The webcast will be archived for 90 days following the live presentation.

About Fluidigm

Fluidigm FLDM develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single-cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.

Contact:

Fluidigm Corporation

Ana Petrovic

Director, Corporate Development and Investor Relations

650 243 6628 (Office)

ana.petrovic@fluidigm.com